Roger Song
Stock Analyst at Jefferies
(2.81)
# 1,858
Out of 4,911 analysts
47
Total ratings
36.84%
Success rate
1.91%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Roger Song
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| REPL Replimune Group | Maintains: Buy | $31 → $6 | $3.15 | +90.48% | 2 | Jul 22, 2025 | |
| VERV Verve Therapeutics | Downgrades: Hold | $28 → $11 | $11.20 | -1.79% | 1 | Jun 18, 2025 | |
| CVAC CureVac | Downgrades: Hold | $7 → $5 | $5.46 | -8.42% | 1 | Jun 13, 2025 | |
| KNSA Kiniksa Pharmaceuticals International, | Maintains: Buy | $40 → $45 | $26.33 | +70.91% | 2 | Apr 29, 2025 | |
| NKTR Nektar Therapeutics | Upgrades: Buy | $15 → $30 | $25.00 | +20.00% | 11 | Apr 11, 2025 | |
| AKBA Akebia Therapeutics | Initiates: Buy | $6 | $3.56 | +68.54% | 1 | Apr 1, 2025 | |
| SANA Sana Biotechnology | Initiates: Buy | $7 | $4.95 | +41.41% | 1 | Mar 14, 2025 | |
| KRYS Krystal Biotech | Initiates: Buy | $245 | $147.61 | +65.98% | 1 | Mar 5, 2025 | |
| WVE Wave Life Sciences | Initiates: Buy | $26 | $8.40 | +209.52% | 1 | Feb 25, 2025 | |
| IGMS IGM Biosciences | Downgrades: Hold | $48 → $2 | $1.27 | +57.48% | 2 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $42 → $7 | $4.62 | +51.52% | 2 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $28 | $6.23 | +349.80% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $2 → $7 | $1.70 | +311.76% | 1 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $89 | $60.50 | +47.11% | 1 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $25 | $7.47 | +234.67% | 2 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $41 | $11.54 | +255.44% | 1 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $15.78 | +121.80% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $5.83 | +54.37% | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $129 | $36.60 | +252.46% | 1 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $2.5 → $8 | $2.40 | +233.33% | 3 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $97 | $81.48 | +19.05% | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $72 | $19.77 | +264.19% | 2 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $110 | $34.42 | +219.58% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $35 | $4.08 | +757.84% | 1 | Aug 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $0.94 | +853.69% | 1 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $4.71 | +69.85% | 2 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $21 | $0.89 | +2,267.00% | 1 | Sep 2, 2020 |
Replimune Group
Jul 22, 2025
Maintains: Buy
Price Target: $31 → $6
Current: $3.15
Upside: +90.48%
Verve Therapeutics
Jun 18, 2025
Downgrades: Hold
Price Target: $28 → $11
Current: $11.20
Upside: -1.79%
CureVac
Jun 13, 2025
Downgrades: Hold
Price Target: $7 → $5
Current: $5.46
Upside: -8.42%
Kiniksa Pharmaceuticals International,
Apr 29, 2025
Maintains: Buy
Price Target: $40 → $45
Current: $26.33
Upside: +70.91%
Nektar Therapeutics
Apr 11, 2025
Upgrades: Buy
Price Target: $15 → $30
Current: $25.00
Upside: +20.00%
Akebia Therapeutics
Apr 1, 2025
Initiates: Buy
Price Target: $6
Current: $3.56
Upside: +68.54%
Sana Biotechnology
Mar 14, 2025
Initiates: Buy
Price Target: $7
Current: $4.95
Upside: +41.41%
Krystal Biotech
Mar 5, 2025
Initiates: Buy
Price Target: $245
Current: $147.61
Upside: +65.98%
Wave Life Sciences
Feb 25, 2025
Initiates: Buy
Price Target: $26
Current: $8.40
Upside: +209.52%
IGM Biosciences
Jan 10, 2025
Downgrades: Hold
Price Target: $48 → $2
Current: $1.27
Upside: +57.48%
Dec 9, 2024
Downgrades: Hold
Price Target: $42 → $7
Current: $4.62
Upside: +51.52%
Nov 21, 2024
Maintains: Buy
Price Target: $32 → $28
Current: $6.23
Upside: +349.80%
Nov 19, 2024
Upgrades: Buy
Price Target: $2 → $7
Current: $1.70
Upside: +311.76%
Oct 23, 2024
Initiates: Buy
Price Target: $89
Current: $60.50
Upside: +47.11%
Oct 16, 2024
Maintains: Buy
Price Target: $31 → $25
Current: $7.47
Upside: +234.67%
Oct 11, 2024
Initiates: Buy
Price Target: $41
Current: $11.54
Upside: +255.44%
Oct 8, 2024
Initiates: Buy
Price Target: $35
Current: $15.78
Upside: +121.80%
Sep 5, 2024
Initiates: Buy
Price Target: $9
Current: $5.83
Upside: +54.37%
Sep 3, 2024
Maintains: Buy
Price Target: $108 → $129
Current: $36.60
Upside: +252.46%
May 6, 2024
Upgrades: Buy
Price Target: $2.5 → $8
Current: $2.40
Upside: +233.33%
Apr 17, 2024
Initiates: Buy
Price Target: $97
Current: $81.48
Upside: +19.05%
Mar 20, 2024
Maintains: Buy
Price Target: $41 → $72
Current: $19.77
Upside: +264.19%
Mar 7, 2024
Initiates: Buy
Price Target: $110
Current: $34.42
Upside: +219.58%
Aug 31, 2022
Maintains: Buy
Price Target: $30 → $35
Current: $4.08
Upside: +757.84%
Jul 29, 2022
Initiates: Buy
Price Target: $9
Current: $0.94
Upside: +853.69%
Dec 1, 2021
Initiates: Buy
Price Target: $8
Current: $4.71
Upside: +69.85%
Sep 2, 2020
Initiates: Buy
Price Target: $21
Current: $0.89
Upside: +2,267.00%